Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples